Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review

S Rosson, R De Filippis, G Croatto, E Collantoni… - Neuroscience & …, 2022 - Elsevier
Background The degree of efficacy, safety, quality, and certainty of meta-analytic evidence of
biological non-pharmacological treatments in mental disorders is unclear. Methods We …

Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment

M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida… - Molecular …, 2022 - nature.com
Antipsychotic drugs are the mainstay in the treatment of schizophrenia. However, one-third
of patients do not show adequate improvement in positive symptoms with non-clozapine …

EPA guidance on treatment of negative symptoms in schizophrenia

S Galderisi, S Kaiser, I Bitter, M Nordentoft… - European …, 2021 - cambridge.org
Negative symptoms of schizophrenia remain a major therapeutic challenge. The progress in
the conceptualization and assessment is not yet fully reflected by treatment research …

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

JP Lefaucheur, N André-Obadia, A Antal… - Clinical …, 2014 - Elsevier
A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until …

Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress

R Magierski, T Sobow, E Schwertner… - Frontiers in …, 2020 - frontiersin.org
The core symptoms of different dementia subtypes are the behavioral and psychological
symptoms of dementia (BPSD) and its neuropsychiatric symptoms (NPS). BPSD symptoms …

Boosting psychological change: Combining non-invasive brain stimulation with psychotherapy

E Tatti, AL Phillips, R Paciorek, SM Romanella… - Neuroscience & …, 2022 - Elsevier
Mental health disorders and substance use disorders are a leading cause of morbidity and
mortality worldwide, and one of the most important challenges for public health systems …

Efficacy and safety of transcranial direct current stimulation for treating negative symptoms in schizophrenia: a randomized clinical trial

LCL Valiengo, S Goerigk, PC Gordon… - Jama …, 2020 - jamanetwork.com
Importance Negative symptoms represent a substantial burden in schizophrenia. Although
preliminary studies have suggested that transcranial direct current stimulation (tDCS) is …

The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis

R Lorentzen, TD Nguyen, A McGirr, F Hieronymus… - Schizophrenia, 2022 - nature.com
Several trials have shown preliminary evidence for the efficacy of transcranial magnetic
stimulation (TMS) as a treatment for negative symptoms in schizophrenia. Here, we …

Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders

A Broncel, R Bocian, P Kłos-Wojtczak… - Brain research …, 2020 - Elsevier
Vagal nerve stimulation (VNS) is known as an effective method of treatment in a number of
neurological disorders. The low risk of side effects also makes it useful in clinical trials in …

Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative …

R Basavaraju, D Ithal, MV Thanki… - Schizophrenia …, 2021 - Elsevier
Objective Negative symptoms of schizophrenia are substantially disabling and treatment
resistant. Novel treatments like repetitive transcranial magnetic stimulation (TMS) need to be …